Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Monness, Crespi, Hardt Downgrades Salesforce to Neutral

Monness, Crespi, Hardt Downgrades Salesforce to Neutral

Monness, Crespi, Hardt analyst Brian White downgrades Salesforce (NYSE:CRM) from Buy to Neutral.

byBenzinga Newsdesk

November 17, 2022

1 minute read

Monness, Crespi, Hardt analyst Brian White downgrades Salesforce (NYSE:CRM) from Buy to Neutral.

Morgan Stanley Maintains Equal-Weight on Exscientia, Lowers Price Target to $15

By Benzinga Newsdesk

September 9, 8:49 AM

Morgan Stanley analyst Vikram Purohit maintains Exscientia (NASDAQ:EXAI) with a Equal-Weight and lowers the price target from $18 to $15.

EXAI

Movers
News

What’s Going On With Ford Stock?

By Adam Eckert

July 17, 8:58 AM

Ford Motor Co (NYSE: F) shares are trading lower. The company on Monday announced price cuts for its F-150 Lightning truck.

Syros Pharmaceuticals To Present Initial Data From SELECT-AML-1 Phase 2 Trial At 64th ASH Annual Meeting

By Benzinga Newsdesk

November 3, 9:22 AM

Syros Pharmaceuticals (NASDAQ:SYRS), a leader in the development of medicines that control the expression of genes, today announced that it will present initial data from the safety lead-in portion of its ongoing

SYRS

Analyst Confidence Skyrockets in Broadcom: A Glimpse into Its Lucrative AI Future?

By Anusuya Lahiri

December 12, 9:22 AM

Citigroup analyst Christopher Danely reinstated Broadcom Inc (NASDAQ: AVGO) with a Buy and a

AVGO

Monness, Crespi, Hardt Downgrades Salesforce to Neutral

Related Posts

Morgan Stanley Maintains Equal-Weight on Exscientia, Lowers Price Target to $15

What’s Going On With Ford Stock?

Syros Pharmaceuticals To Present Initial Data From SELECT-AML-1 Phase 2 Trial At 64th ASH Annual Meeting

Analyst Confidence Skyrockets in Broadcom: A Glimpse into Its Lucrative AI Future?